Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy
Yuanyuan Liu, Linan Qiao, Sipei Zhang, et al.
Acta Biomaterialia (2017) Vol. 66, pp. 310-324
Closed Access | Times Cited: 188

Showing 26-50 of 188 citing articles:

The state of CD44 activation in cancer progression and therapeutic targeting
Qian Guo, Cuixia Yang, Feng Gao
FEBS Journal (2021) Vol. 289, Iss. 24, pp. 7970-7986
Open Access | Times Cited: 91
Active Cellular and Subcellular Targeting of Nanoparticles for Drug Delivery
Okhil K. Nag, James B. Delehanty
Pharmaceutics (2019) Vol. 11, Iss. 10, pp. 543-543
Open Access | Times Cited: 86
Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy
Marta Truffi, Serena Mazzucchelli, Arianna Bonizzi, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1263-1263
Open Access | Times Cited: 85
Role of cell surface proteoglycans in cancer immunotherapy
Nancy Adriana Espinoza‐Sánchez, Martin Götte
Seminars in Cancer Biology (2019) Vol. 62, pp. 48-67
Closed Access | Times Cited: 85
Leukocyte/platelet hybrid membrane-camouflaged dendritic large pore mesoporous silica nanoparticles co-loaded with photo/chemotherapeutic agents for triple negative breast cancer combination treatment
Tao Zhang, Hui Liu, Ling Li, et al.
Bioactive Materials (2021) Vol. 6, Iss. 11, pp. 3865-3878
Open Access | Times Cited: 83
pH-Responsive Nanoparticles for Cancer Immunotherapy: A Brief Review
Yunfeng Yan, Hangwei Ding
Nanomaterials (2020) Vol. 10, Iss. 8, pp. 1613-1613
Open Access | Times Cited: 75
Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis
Xiaoyan Gu, Yunzhen Gao, Ping Wang, et al.
Journal of Controlled Release (2021) Vol. 333, pp. 374-390
Closed Access | Times Cited: 64
Targeting Engineered Nanoparticles for Breast Cancer Therapy
Kumar Ganesan, Yan Wang, Fei Gao, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1829-1829
Open Access | Times Cited: 63
Recent advances in immunotherapy, immunoadjuvant, and nanomaterial-based combination immunotherapy
Benqing Zhou, Jinxing Liu, Meiai Lin, et al.
Coordination Chemistry Reviews (2021) Vol. 442, pp. 214009-214009
Closed Access | Times Cited: 62
Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer
Qingxin Mu, Guanyou Lin, Mike Jeon, et al.
Materials Today (2021) Vol. 50, pp. 149-169
Open Access | Times Cited: 56
Intelligent poly(l-histidine)-based nanovehicles for controlled drug delivery
Yu Zhang, Il Kim, Yiming Lu, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 963-982
Closed Access | Times Cited: 55
Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer
Naveen Rajana, Aare Mounika, Padakanti Sandeep Chary, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 1024-1047
Closed Access | Times Cited: 52
Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials
Syed Nasir Abbas Bukhari
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 866-866
Open Access | Times Cited: 47
Exosome-mediated delivery of transforming growth factor-β receptor 1 kinase inhibitors and toll-like receptor 7/8 agonists for combination therapy of tumors
Joo Hang Lee, Ji‐Hyeon Song, In Gyu Kim, et al.
Acta Biomaterialia (2022) Vol. 141, pp. 354-363
Closed Access | Times Cited: 38
Polysaccharide‐Based Stimulus‐Responsive Nanomedicines for Combination Cancer Immunotherapy
Qiuxia Li, Xing Liu, Chunmei Yan, et al.
Small (2023) Vol. 19, Iss. 23
Closed Access | Times Cited: 37
The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies
Fan Yang, Qingjie He, Xiangpeng Dai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 27
Research Progress on Stimulus-Responsive Polymer Nanocarriers for Cancer Treatment
Shicui Luo, Zhuo Lv, Qiuqiong Yang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1928-1928
Open Access | Times Cited: 26
Smart nanogels for cancer treatment from the perspective of functional groups
Jiachen Yu, Yuting Liu, Yingchun Zhang, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 11
Open Access | Times Cited: 13
Hyaluronic Acid-Based Drug Delivery Systems for Cancer Therapy
Ekaterina Pashkina, М. В. Быкова, M. T. Berishvili, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 61-61
Open Access | Times Cited: 1
Nano delivery systems and cancer immunotherapy
Quoc‐Viet Le, Jin-Joo Choi, Yu‐Kyoung Oh
Journal of Pharmaceutical Investigation (2018) Vol. 48, Iss. 5, pp. 527-539
Closed Access | Times Cited: 71
pH and redox dual-responsive nanoparticles based on disulfide-containing poly(β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer
Sipei Zhang, Nan Guo, Guoyun Wan, et al.
Journal of Nanobiotechnology (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 68
Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes
Menghao Shi, Jiulong Zhang, Xiaowei Li, et al.
International Journal of Nanomedicine (2018) Vol. Volume 13, pp. 4209-4226
Open Access | Times Cited: 60
Emerging nanomedicines for effective breast cancer immunotherapy
Amirhossein Bahreyni, Yasir Mohamud, Honglin Luo
Journal of Nanobiotechnology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 58
Toll-like receptor-targeted particles: A paradigm to manipulate the tumor microenvironment for cancer immunotherapy
Tuan Hiep Tran, Thi Thu Phuong Tran, Duy Hieu Truong, et al.
Acta Biomaterialia (2019) Vol. 94, pp. 82-96
Closed Access | Times Cited: 56
Recent advantage of hyaluronic acid for anti-cancer application: a review of “3S” transition approach
Wei Zhong, Long Pang, Haohui Feng, et al.
Carbohydrate Polymers (2020) Vol. 238, pp. 116204-116204
Closed Access | Times Cited: 51

Scroll to top